Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma.
Fuhr V, Heidenreich S, Srivastava M, Riedel A, Düll J, Gerhard-Hartmann E, Rosenwald A, Rauert-Wunderlich H. Fuhr V, et al. Among authors: dull j. Cell Death Discov. 2022 Dec 31;8(1):505. doi: 10.1038/s41420-022-01289-7. Cell Death Discov. 2022. PMID: 36587029 Free PMC article.
Targeting CD19 in diffuse large B-cell lymphoma: An expert opinion paper.
Bailly S, Cartron G, Chaganti S, Córdoba R, Corradini P, Düll J, Ferrarini I, Osborne W, Rosenwald A, Sancho JM, Tilly H, Van Den Neste E, Viardot A, Visco C. Bailly S, et al. Among authors: dull j. Hematol Oncol. 2022 Oct;40(4):505-517. doi: 10.1002/hon.3013. Epub 2022 Jun 7. Hematol Oncol. 2022. PMID: 35488888 Free PMC article. Review.
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma.
Leipold AM, Werner RA, Düll J, Jung P, John M, Stanojkovska E, Zhou X, Hornburger H, Ruckdeschel A, Dietrich O, Imdahl F, Krammer T, Knop S, Rosenwald A, Buck A, Sander LE, Einsele H, Kortüm KM, Saliba AE, Rasche L. Leipold AM, et al. Among authors: dull j. Leukemia. 2023 Mar;37(3):650-658. doi: 10.1038/s41375-023-01824-0. Epub 2023 Jan 31. Leukemia. 2023. PMID: 36720972 Free PMC article.
A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement.
Rasche L, Menoret E, Dubljevic V, Menu E, Vanderkerken K, Lapa C, Steinbrunn T, Chatterjee M, Knop S, Düll J, Greenwood DL, Hensel F, Rosenwald A, Einsele H, Brändlein S. Rasche L, et al. Among authors: dull j. Clin Cancer Res. 2016 Sep 1;22(17):4341-9. doi: 10.1158/1078-0432.CCR-15-3111. Epub 2016 Mar 30. Clin Cancer Res. 2016. PMID: 27029491
The use of tafasitamab in diffuse large B-cell lymphoma.
Düll J, Topp M, Salles G. Düll J, et al. Ther Adv Hematol. 2021 Jul 6;12:20406207211027458. doi: 10.1177/20406207211027458. eCollection 2021. Ther Adv Hematol. 2021. PMID: 34285786 Free PMC article. Review.
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression.
Jabbour E, Düll J, Yilmaz M, Khoury JD, Ravandi F, Jain N, Einsele H, Garcia-Manero G, Konopleva M, Short NJ, Thompson PA, Wierda W, Daver N, Cortes J, O'brien S, Kantarjian H, Topp MS. Jabbour E, et al. Among authors: dull j. Am J Hematol. 2018 Mar;93(3):371-374. doi: 10.1002/ajh.24987. Epub 2017 Dec 23. Am J Hematol. 2018. PMID: 29178361 Free article.
Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma.
Riedhammer C, Düll J, Kestler C, Kadel S, Franz J, Weis P, Eisele F, Zhou X, Steinhardt M, Scheller L, Mersi J, Waldschmidt JM, Einsele H, Turnwald D, Kortüm KM, Surat G, Rasche L. Riedhammer C, et al. Among authors: dull j. Ann Hematol. 2024 Apr;103(4):1327-1332. doi: 10.1007/s00277-023-05586-8. Epub 2023 Dec 20. Ann Hematol. 2024. PMID: 38123879 Free PMC article.
27 results